Zobrazeno 1 - 10 of 53 pro vyhledávání: '"U, Sancken"'
2
Maternal Serum Placental Growth Hormone and Insulinlike Growth Factor Binding Proteins 1 and 3 in Pregnancies Affected by Fetal Aneuploidy and Other Abnormalities: Implications for Prenatal Diagnosis of Trisomy 21
Autor: G. Hennen, S. Moghadam, A. Igout, U. Sancken, M. Bougoussa, W. Engel
Publikováno v: Fetal Diagnosis and Therapy. 13:291-297
In the present study, we determined circulating serum levels of human placental growth hormone (hPGH) and insulinlike growth factor binding proteins 1 and 3 (IGFBP-1 and IGFBP-3) using two-site radioimmunoassays during the gestational midtrimester of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac3ec8aeafda83110d3fcad2224ca03
https://doi.org/10.1159/000020856
Zobrazit plný text záznamu
5
Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG)
Autor: U. Sancken, D. Bahner
Publikováno v: Fetal diagnosis and therapy. 18(2)
Objective: Second trimester total hCG and free βhCG levels in maternal serum samples of 33 pregnancies affected by fetal trisomy 21 and of 188 matched controls were compared in a retrospective study. To find out differences of discriminating efficac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a32992bc3fd8ccf2f612d604309957c6
https://pubmed.ncbi.nlm.nih.gov/12576748
Zobrazit plný text záznamu
6
A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories
Autor: U, Sancken, I, Bartels, F, Louwen, B, Eiben
Publikováno v: Prenatal diagnosis. 19(10)
A retrospective study on screening methods for fetal trisomy 18 has been carried out in two different laboratories using the serum parameters: total human chorionic gonadotropin (hCG), unconjugated oestriol (uE3), and alpha-fetoprotein (AFP) in diffe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2edc2cc9f913cf61e5cc30d093d311d5
https://pubmed.ncbi.nlm.nih.gov/10521821
Zobrazit plný text záznamu
7
[Prenatal risk index for fetal Down's syndrome with serum markers. Comment on the contribution by R. Benz, U. Müller, M. Krahner-Pilat, S. Wagner-Geuder, R. Terinde: Serum screening for Down's syndrome in women less than 35 years of age with an age-independent index]
Autor: I, Bartels, U, Sancken
Publikováno v: Zeitschrift fur Geburtshilfe und Perinatologie. 198(4)
5 years ago, maternal serum markers have been established for individual risk estimation of fetal Down syndrome. Recently Benz et al. presented an arbitrary age-independent risk index. Compared to the commonly applied statistical approach a 20% incre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e7ba22632afa0b0084774523501b8f08
https://pubmed.ncbi.nlm.nih.gov/7526565
Zobrazit plný text záznamu
9
Akademický článek
Comparison of Triple-Risk Assessment of Fetal Trisomy 21 Including Total Human Choriogonadotropin (hCG) or Its Free β-Subunit (Free βhCG).
Autor: U. Sancken, D. Bahner
Publikováno v: Fetal Diagnosis & Therapy; Mar/Apr2003, Vol. 18 Issue 2, p122-127, 6p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje